Welcome to our dedicated page for NuSkin Enterprises news (Ticker: $NUS), a resource for investors and traders seeking the latest updates and insights on NuSkin Enterprises stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect NuSkin Enterprises's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of NuSkin Enterprises's position in the market.
Nu Skin Enterprises Inc. (NYSE: NUS) reported first-quarter results in line with guidance, with revenue at $417.3 million, a 13.3% decrease YoY. The Rhyz business saw a 57.5% growth. Earnings per share were $(0.01), impacted by restructuring charges. Customer and affiliate numbers declined, but new product launches showed promise. Despite challenges, the company is focused on long-term growth and shareholder value.
Nu Skin Enterprises, Inc. (NYSE: NUS) declared a quarterly cash dividend of $0.06 per share to be paid on June 12, 2024, to shareholders of record on May 31, 2024.
